Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

Cell host & microbe | Feb 16, 2012

http://www.ncbi.nlm.nih.gov/pubmed/22341466

The human and simian immunodeficiency viruses (HIV and SIV) primarily infect lymphocytes, which must be activated for efficient viral replication. We show that the cytoplasmic domain of the transmembrane glycoprotein gp41 (gp41CD) of both HIV-1 and SIV induces activation of NF-κB, a cellular factor important for proviral genome transcription and lymphocyte activation. This NF-κB activating property localized to a region 12-25 (SIV) or 59-70 (HIV-1) residues from the gp41 membrane-spanning domain. An siRNA-based screen of 42 key NF-κB regulators revealed that gp41CD-mediated activation occurs through the canonical NF-κB pathway via TGF-β-activated kinase 1 (TAK1). TAK1 activity was required for gp41CD-mediated NF-κB activation, and HIV-1-derived gp41CD physically interacted with TAK1 through the same region required for NF-κB activation. Importantly, an NF-κB activation-deficient HIV-1 mutant exhibited increased dependence on cellular activation for replication. These findings demonstrate an evolutionarily conserved role for gp41CD in activating NF-κB to promote infection.

Pubmed ID: 22341466 RIS Download

Mesh terms: Cell Line | HIV Envelope Protein gp41 | HIV-1 | Humans | Intracellular Signaling Peptides and Proteins | Lymphocyte Activation | NF-kappa B | Protein Binding | Protein Interaction Mapping | Simian immunodeficiency virus | Virus Replication

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, Id: 5R01AI025328
  • Agency: NCRR NIH HHS, Id: P51 RR000168-50
  • Agency: NIAID NIH HHS, Id: R01 AI025328
  • Agency: NIAID NIH HHS, Id: R01 AI025328-20
  • Agency: NIAID NIH HHS, Id: R01 AI025328-21
  • Agency: NIAID NIH HHS, Id: R01 AI025328-22
  • Agency: NIAID NIH HHS, Id: R01 AI025328-23
  • Agency: NCRR NIH HHS, Id: RR00168

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.